For example, high serum levels of TIMP1 are promising indicators of poor overall survival of breast cancer patients [76], whereas high serum levels of MMP-9 have been demonstrated to strongly predict response to treatment and metastasis [72, 144]. Here, TIMP1 is linked to breast carcinoma.